Johnson & Johnson said its clinical trial for the Shockwave Javelin catheter had a 93.6% success rate.
Good or bad for JNJ?
This is a Prominent story. The full analysis, including whether it is good or bad for JNJ, is available with Pro or after its release time. It opens to free readers on Nov 2, 2026, 9:31 PM ET.
Get alerts for JNJ
Follow Johnson & Johnson (JNJ) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for JNJFree on the App Store and Google Play, or on the web.